Antibiotic Discovery and Resistance: The Chase and the Race

Abstract

The history of antimicrobial resistance (AMR) evolution and the diversity of the environmental resistome indicate that AMR is an ancient natural phenomenon. Acquired resistance is a public health concern influenced by the anthropogenic use of antibiotics, leading to the selection of resistant genes. Data show that AMR is spreading globally at different rates, outpacing all efforts to mitigate this crisis. The search for new antibiotic classes is one of the key strategies in the fight against AMR. Since the 1980s, newly marketed antibiotics were either modifications or improvements of known molecules. The World Health Organization (WHO) describes the current pipeline as bleak, and warns about the scarcity of new leads. A quantitative and qualitative analysis of the pre-clinical and clinical pipeline indicates that few antibiotics may reach the market in a few years, predominantly not those that fit the innovative requirements to tackle the challenging spread of AMR. Diversity and innovation are the mainstays to cope with the rapid evolution of AMR. The discovery and development of antibiotics must address resistance to old and novel antibiotics. Here, we review the history and challenges of antibiotics discovery and describe different innovative new leads mechanisms expected to replenish the pipeline, while maintaining a promising possibility to shift the chase and the race between the spread of AMR, preserving antibiotic effectiveness, and meeting innovative leads requirements.

A Focused Insight into Thyme: Biological, Chemical, and Therapeutic Properties of an Indigenous Mediterranean Herb

“…Several existing gaps complicate the problem of AMR, including extremely slow innovation, vaccine shortages, dry clinical pipelines, and episodic, uneven action from policymakers [ 84 ]. Data show that AMR growth rates exceed all efforts to ameliorate the situation, and the search for new antibiotic classes remains one of the most important strategies in the battle against this crisis [ 85 ]. In the search for creative approaches to tackle AMR, natural products offer a promising supply of antibacterial lead compounds, which could help fill the drug discovery void as the antibiotic resistance situation worsens [ 86 ].…”

Phytochemical Screening, Antioxidant, and Antimicrobial Activities of Seven Underinvestigated Medicinal Plants against Microbial Pathogens

“…The emergence and spread of drug-resistant pathogens that have acquired new resistance mechanisms, leading to antimicrobial resistance, continues to threaten our ability to treat common infections [ 1 ]. Especially alarming is the rapid global spread of multi- and pan-resistant bacteria (also known as “superbugs”) that cause infections that are not treatable with existing antimicrobial medicines such as antibiotics or antifungals [ 2 ].…”

2,3-Dehydrokievitone combats methicillin-resistant Staphylococcus aureus infection by reducing alpha-hemolysin expression

“…Alternative strategies to tackle infections of S. aureus have been reported include phage therapy, antivirulence therapy, antimicrobial peptides, vaccines, and others ( Iskandar et al, 2022 ). S. aureus utilizes a variety of virulence factors to invade the host and allow it to survive, including binding to host cells and facilitating colonization to kill or change signal transduction in host cells.…”